A Study to see the benefits of adding tablet letrozole to the usual extended cycle oral contraceptive pills in reduction of endometriosis related of pain.
Phase 4
- Conditions
- Health Condition 1: - Health Condition 2: N809- Endometriosis, unspecified
- Registration Number
- CTRI/2020/08/027497
- Lead Sponsor
- Internal Fluid Research
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Women in reproductive age group of 18 to 45years not planning on conceiving for next 6months and diagnosed with endometriosis.
2.Women who are planned for medical management and not for surgical
management.
3.Women with pain score of more than or equal to seven in Numerical rating scale.
Exclusion Criteria
1.Post menopausal women.
2.Women planning on conceiving in the next 6months.
3.Women who took therapies other than NSAIDs for 3months prior to inclusion in the study.
4.Previous use of aromatase inhibitors.
5.Women with osteoporosis or osteopenia.
6.Women with past or present history of seizure disorders, pulmonary, cardiac, hepatic or renal diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method